Literature DB >> 8799631

The medical management of hyperglycemia over a 10-year period in people with diabetes.

R Klein1, B E Klein, S E Moss, K J Cruickshanks.   

Abstract

OBJECTIVE: The purpose of the study was to examine changes in the medical management of glycemia in diabetes and its relation to changes in hyperglycemia as measured by glycated hemoglobin. RESEARCH DESIGN AND METHODS: A total of 765 patients with younger-onset diabetes diagnosed before 30 years of age and 533 older-onset diabetic patients participated in a population-based study in southern Wisconsin, at baseline (1980-1982), at 4 years (1984-1986), and at 10 years (1990-1992). Glycated hemoglobin, the presence of complications, and information regarding medical management of glycemia, hypoglycemic reactions, and socioeconomic factors were determined using standardized protocols at the three examinations.
RESULTS: In the younger-onset group, there was a significant increase (P < 0.001) in the use of three or more insulin injections per day or in the use of an insulin infusion pump from 3.6% of the cohort at baseline to 24.4% at the 10-year follow-up. This increase was associated with female sex, the presence of gross proteinuria, more education, and better glycemic control at baseline. In the older-onset group, there was a significant (P < 0.05) increase in the proportion of patients taking insulin, from 49.2% at baseline to 61.9% at the 10-year follow-up. This was associated with being younger, having a longer duration of diabetes, having higher glycated hemoglobin values, and having more education at baseline, or developing proliferative diabetic retinopathy or macular edema between baseline and the 4-year follow-up.
CONCLUSIONS: These data suggest a change in the pattern of use of insulin to treat people with diabetes. However, there is still a large number of individuals with poorly controlled diabetes in the population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799631     DOI: 10.2337/diacare.19.7.744

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Blood pressure control and diabetic retinopathy.

Authors:  R Klein; B E K Klein
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Diabetes, diversity, and disparity: what do we do with the evidence?

Authors:  Sandra A Black
Journal:  Am J Public Health       Date:  2002-04       Impact factor: 9.308

3.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.

Authors:  Ronald Klein; Michael D Knudtson; Kristine E Lee; Ronald Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2008-11       Impact factor: 12.079

4.  A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

Authors:  P D Home; C J Bailey; J Donaldson; H Chen; M W Stewart
Journal:  Diabet Med       Date:  2007-04-02       Impact factor: 4.359

5.  A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine.

Authors:  Chantal Mathieu; R Ravi Shankar; Daniel Lorber; Guillermo Umpierrez; Fan Wu; Lei Xu; Gregory T Golm; Melanie Latham; Keith D Kaufman; Samuel S Engel
Journal:  Diabetes Ther       Date:  2015-03-28       Impact factor: 2.945

6.  Impact of Disease Duration on the Effects of Pramlintide in Type 1 Diabetes: A Post Hoc Analysis of Three Clinical Trials.

Authors:  Kathrin Herrmann; Steven C Brunell; Yan Li; Ming Zhou; David G Maggs
Journal:  Adv Ther       Date:  2016-04-12       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.